Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

BioRestorative Therapies Inc

BRTX
1,55
0,04 (2,65%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/2/202513:57EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
27/2/202515:45GLOBEBioRestorative Announces FDA Clearance of IND for Phase 2..
27/2/202502:15GLOBEBioRestorative Announces Updated Time for February 27th..
25/2/202514:00GLOBEBioRestorative to Provide a Positive FDA Update on Clinical..
20/2/202514:30GLOBEBioRestorative Receives FDA Fast Track Designation for..
19/2/202522:43EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
19/2/202522:39EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
19/2/202522:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202514:32EDGAR2Form 8-K - Current report
10/2/202513:00GLOBEBRTX-100 Front and Center at ORS 2025
05/12/202412:45GLOBEBioRestorative Therapies Announces Notice of Allowance of..
13/11/202413:00GLOBEBioRestorative Therapies Reports Positive Preliminary Phase..
12/11/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:05GLOBEBioRestorative Therapies Reports Third Quarter 2024..
06/11/202422:43EDGAR2Form 8-K - Current report
06/11/202422:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/11/202422:25EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
06/11/202413:00GLOBEBioRestorative Therapies to Present New Clinical Data at the..
05/11/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202413:10GLOBEBioRestorative Therapies Receives Expanded Tissue License..
31/10/202412:00GLOBEBioRestorative Therapies Receives Patent Allowance for..
10/10/202413:00GLOBEBioRestorative Therapies to Participate in Upcoming UBS and..
03/10/202422:15GLOBEBioRestorative Therapies to Participate in the 3rd Annual..
23/9/202422:33EDGAR2Form 8-K - Current report
19/9/202412:55GLOBEBioRestorative Therapies’ IFATS 2024 Presentation to Feature..
13/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:11EDGAR2Form 8-K - Current report
13/8/202422:05GLOBEBioRestorative Therapies Reports Second Quarter 2024..
08/8/202422:23EDGAR2Form DEF 14A - Other definitive proxy statements
06/8/202422:47EDGAR2Form 8-K - Current report
06/8/202422:05GLOBEBioRestorative Therapies to Report Second Quarter 2024..
23/7/202413:10GLOBEBioRestorative Therapies’ Chief Scientist Named New Section..
27/6/202413:40GLOBEBioRestorative Therapies Announces Notice of Allowance for..
17/6/202413:05GLOBEBioRestorative Therapies Regains Compliance with Nasdaq..
13/6/202417:40APSShares of Biotech MicroCap Rip on Licensing Talks
13/6/202413:00GLOBEBioRestorative Therapies in Substantive Discussions for..
11/6/202422:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/6/202422:23EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
04/6/202414:50GLOBEBioRestorative Therapies, Inc. to attend the Jefferies 2024..
25/5/202401:45GLOBEBioRestorative Therapies Announces Receipt of Nasdaq..
24/5/202422:51EDGAR2Form 8-K - Current report
24/5/202422:45EDGAR2Form 8-K - Current report
16/5/202423:17EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14/5/202422:10GLOBEBioRestorative Therapies Provides First Quarter 2024..
08/5/202413:30GLOBEBioRestorative Therapies Enhances Preclinical Metabolic..
Apertura: 1,50 Min: 1,4632 Max: 1,62
Chiusura: 1,51

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network